Efficacy and safety of oral minoxidil 5 mg daily during 24-week treatment in male androgenetic alopecia

被引：0
|
作者：
Lueangarun, Saoraya [1 ]
Panchaprateep, Ratchathorn [1 ]
Tempark, Therdpong [1 ]
Noppakun, Nopadon [1 ]
机构：
[1] King Chulalongkorn Mem Hosp, Bangkok, Thailand
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
638
引用
收藏
页码：AB113 / AB113
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis
    Parsa Abdi
    Christian Awad
    Michelle R. Anthony
    Christopher Farkouh
    Bret Kenny
    Howard I. Maibach
    Boluwaji Ogunyemi
    Archives of Dermatological Research, 2023, 315 : 2775 - 2785
  • [32] Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-Comparison, Sham Device-Controlled Trial
    Fan, Sabrina Mai-Yi
    Cheng, Yu-Pin
    Lee, Ming-Yung
    Lin, Sung-Jan
    Chiu, Hsien-Yi
    DERMATOLOGIC SURGERY, 2018, 44 (11) : 1411 - 1420
  • [33] Efficacy of Minoxidil Combined With Photobiomodulation for the Treatment of Male Androgenetic Alopecia. A Double-Blind Half-Head Controlled Trial
    Ferrara, Fernanda
    Kakizaki, Priscila
    de Brito, Fernanda Freitas
    Contin, Leticia Arsie
    Machado, Carla Jorge
    Donati, Aline
    LASERS IN SURGERY AND MEDICINE, 2021, 53 (09) : 1201 - 1207
  • [34] Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional-comparative study
    Ammar, Amr M.
    Elshahid, Ahmed R.
    Abdel-Dayem, Hamdy A.
    Mohamed, Ahmed A.
    Elsaie, Mohamed L.
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 5790 - 5799
  • [35] EFFICACY AND SAFETY OF A 24-WEEK TREATMENT WITH LANSOPRAZOLE (30 MG/DAY) FOLLOWING HEALING OF PEPTIC LESIONS RESISTANT TO H2 BLOCKERS
    FLEJOU, JF
    POTET, F
    LEMAIRE, M
    GASTROENTEROLOGY, 1993, 104 (04) : A79 - A79
  • [36] A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
    Blume-Peytavi, Ulrike
    Loennfors, Sanna
    Hillmann, Kathrin
    Bartels, Natalie Garcia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (05) : 794 - 800
  • [37] Injections of platelet-rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia
    Wei, Wei
    Zhang, Yuanjing
    Long, Binman
    Zhang, Yuanyuan
    Zhang, Chi
    Zhang, Siping
    SKIN RESEARCH AND TECHNOLOGY, 2023, 29 (07)
  • [38] Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study
    Tundo, Antonio
    Betro, Sophia
    Iommi, Marica
    de Filippis, Rocco
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 112
  • [39] Efficacy and safety of once-daily (OD) fluticasone furoate (FF) in patients with persistent asthma: A 24-week randomised trial
    Lotvall, Jan
    Bleecker, Eugene
    Busse, William
    O'Byrne, Paul
    Woodcock, Ashley
    Bateman, Eric
    Kerwin, Edward
    Stone, Sally
    Forth, Richard
    Jacques, Loretta
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [40] A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
    King, Brett
    Guttman-Yassky, Emma
    Peeva, Elena
    Banerjee, Anindita
    Sinclair, Rodney
    Pavel, Ana B.
    Zhu, Linda
    Cox, Lori Ann
    Craiglow, Brittany
    Chen, Linda
    Banfield, Christopher
    Page, Karen
    Zhang, Weidong
    Vincent, Michael S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (02) : 379 - 387
12345